These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 9496556

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. Glucose effectiveness in two subtypes within impaired glucose tolerance. A minimal model analysis.
    Taniguchi A, Nakai Y, Doi K, Fukushima M, Nagata I, Kawamura H, Imura H, Suzuki M, Tokuyama K.
    Diabetes; 1994 Oct; 43(10):1211-7. PubMed ID: 7926290
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. Contribution of total and intact proinsulins to hyperinsulinism in subjects with obesity, impaired glucose tolerance or type 2 diabetes.
    Blicklé JF, Sapin R, Andrès E.
    Diabetes Metab; 2000 Sep; 26(4):274-80. PubMed ID: 11011219
    [Abstract] [Full Text] [Related]

  • 70. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes.
    O'Rahilly S, Turner RC, Matthews DR.
    N Engl J Med; 1988 May 12; 318(19):1225-30. PubMed ID: 3283553
    [Abstract] [Full Text] [Related]

  • 71. Effects of very-low-calorie diet weight reduction on glucose tolerance, insulin secretion, and insulin resistance in obese non-insulin-dependent diabetics.
    Fukuda M, Tahara Y, Yamamoto Y, Onishi T, Kumahara Y, Tanaka A, Shima K.
    Diabetes Res Clin Pract; 1989 Jun 20; 7(1):61-7. PubMed ID: 2666069
    [Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Beta-cell function improvement after biliopancreatic diversion in subjects with type 2 diabetes and morbid obesity.
    Briatore L, Salani B, Andraghetti G, Maggi D, Adami GF, Scopinaro N, Cordera R.
    Obesity (Silver Spring); 2010 May 20; 18(5):932-6. PubMed ID: 20186136
    [Abstract] [Full Text] [Related]

  • 75. The relationship between insulin resistance and insulin secretion in Japanese subjects with borderline glucose intolerance.
    Wasada T, Arii H, Kuroki H, Saeki A, Katsumori K, Saito S, Omori Y.
    Diabetes Res Clin Pract; 1995 Oct 20; 30(1):53-7. PubMed ID: 8745206
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. Effects of weight loss on insulin secretion and in vivo insulin sensitivity in obese diabetic and non-diabetic subjects.
    Escalante-Pulido M, Escalante-Herrera A, Milke-Najar ME, Alpizar-Salazar M.
    Diabetes Nutr Metab; 2003 Oct 20; 16(5-6):277-83. PubMed ID: 15000438
    [Abstract] [Full Text] [Related]

  • 80. Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women.
    Kopp HP, Krzyzanowska K, Möhlig M, Spranger J, Pfeiffer AF, Schernthaner G.
    Int J Obes (Lond); 2005 Jul 20; 29(7):766-71. PubMed ID: 15917853
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.